Net change measures a security's price difference from one day to the next. Learn its role in stock analysis, how it's used ...
Viking Therapeutics recently completed patient enrollment in an exploratory maintenance dosing study of VK2735, its dual ...
Vera Therapeutics recently announced that the U.S. FDA accepted its Biologics License Application for atacicept in adults ...
Liquidia Corporation remains a Buy for risk-tolerant biotech investors, supported by strong Yutrepia launch metrics and ...
Think you need to master dozens of trading patterns to make millions in the stock market? Think again… Throughout my 15 years ...
SELLAS Life Sciences Group recently reported that its Phase 3 REGAL trial of galinpepimut‑S (GPS) in Acute Myeloid Leukemia had reached 72 of the 80 overall-survival events required for final analysis ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
The San Francisco 49ers have finally clarified their stance on Jake Tonges, listing him as the third-string tight end on the depth chart. Tonges became a key contributor in the first half of the ...
If you are a dynasty manager always looking for wins around the margins, you are constantly looking for trades that can help you get where you want to go. Fortunately, DLF provides the Dynasty Trade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback